Article
JMM profile: rifampicin: a broad-spectrum antibiotic
5 Aug 2022
Abstract excerpt
Rifampicin (also known as rifampin) inhibits RNA synthesis, and is used to treat tuberculosis, leprosy, staphylococcal infections and legionnaires’ disease. It can also protect at-risk populations from Haemophilus influenzae type b and Neisseria meningitidis . It is a polyketide antibiotic and is on the World Health Organization (WHO) list of essential medicines due to its critical importance to human medicine....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
